TECH OUTLOOK 6APRIL - 2022TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comClinical transformation accelerated the speed of trial execution during the COVID-19 pandemic. As the pharmaceutical companies raced to find treatments and vaccines, life sciences researchers came together to deliver innovation faster. Despite these leaps forward, the industry recognizes the pace is not sustainable due to the regulatory changes and cross-company collaboration it took to get there. More work remains to drive the long-lasting change in trials to modernize clinical systems, and contract research organizations (CROs) are leading the way. CROs are taking significant action to fasten research studies' execution by investing in new digital strategies and technologies that bring together trial study processes. These efforts are driving more streamlined and connected ways of conducting research.Today, by increasing efficiency in major clinical areas and improving collaboration across the trial ecosystem, CROs are advancing the industry toward patient-centric digital trials to enhance recruitment and retention with the right patient-centric technology. As we advance, CROs will embrace mobile and texting programs more for data collection and keep participants engaged. This modernization will elevate the industry to a new level of connectivity that will benefit life sciences and patients in the future years to come.In this edition of Pharma Tech Outlook, we bring you the story of some of the leading and emerging CROs that deliver the best outcomes for their clients. This edition also offers a combination of thought leadership articles from subject matter experts and exclusive insights from CIOs and CXOs. We hope this edition will provide you with the right assistance in choosing the CROs that fits your business requirements.Let us know your thoughts!The Tech-Driven, Patient- and Workflow-Centric Future of CROsCopyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.APRIL - 18 - 2022, Vol 08 - Issue 01 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com Disclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsEditor-in-ChiefStacey SmithVisualizerRonald DonovanAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, TECH OUTLOOK
< Page 5 | Page 7 >